While either drug can be quite effective, a recent study has found that people taking Zepbound (tirzepatide) have had better results than people taking Wegovy (semaglutide)
Clinical trials have demonstrated that these medications can result in substantial weight loss and decreased incidence of obesity-related comorbidities , such as type 2 diabetes and cardiovascular disease
Theyre gaining fat back, not muscle
The Shifting Habits of Consumers Taking 3+ Prescriptions Daily CivicScience data highlights three areas Americans taking at least three prescription medications daily have altered their spending and eating habits recently and over the past two years: Theyre prioritizing spending less on clothing, shoes, and apparel (50%)
DSIP blocks cortisol release while ashwagandha modulates the HPA axis more broadly
If you already know what you are dealing with, use the selector below to jump directly to your section